Bagher Amirheidari

Dr. Bagher Amirheidari

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

10 September 2023 in Shiraz E-Medical Journal
Verified
Journal Article
Open access
PDF file
SBSaeid Beikmohammadi
Saeid Beikmohammadi
BABagher Amirheidari
Bagher Amirheidari
TDTania Dehesh
Tania Dehesh
MNMahmood Nekoei-Moghadam
Mahmood Nekoei-Moghadam
VYVahid Yazdi-Feyzabadi
Vahid Yazdi-Feyzabadi
HHHossein Habibzadeh
Hossein Habibzadeh
Background: Hospitals are the front line of dealing with Incidents. Chemical, biological, radiological, and nuclear (CBRN) incidents are alarming for governments' healthcare providers and the public. Therefore, they must make the necessary preparations to deal with these incidents. Objectives: This study aimed to evaluate the preparedness of hospitals against chemical, biological, radiological, and nuclear incidents and the related influential factors. Methods: The present study was a cross-sectional survey in northwest Iran, 2020-2022. The statistical population was the hospitals of West Azerbaijan province. The inclusion criteria were that hospitals must be university or therapeutic affiliated with the West Azerbaijan University of Medical Sciences, and at least one year had to be passed since the hospital’s operation. Also, the exclusion criteria were that the hospitals were on the verge of closing or changing their use. In this way, 26 hospitals in West Azerbaijan were studied. The "Canadian Center for Emergency Preparedness" evaluation checklist research tool was used to determine the level of preparedness of the studied hospitals in CBRN incidents. The data was collected for 5 months, from January to May 2021. Cronbach's alpha score for this checklist was 0.94. Descriptive and analytical statistics indicators were used for data analysis using SPSS 20 software. Results: The study showed that the hospitals lacked the preparation, capacities, and abilities to deal with CBRN incidents. In the single-variable mode, in the chemical dimension, the number of morgues of the deceased (P = 0.006); in the biological aspect, per capita educational factors in the biological domain (P = 0.03), the number of facility personnel (P = 0.04), the number of infectious disease specialists (P = 0.02), the number of equipment with optimal laboratory capabilities (P = 0.04), and the number of morgues of the deceased (P = 0.006); in the radiological and nuclear dimensions per capita of nuclear education (P = 0.01) and dosimeter (P = 0.03), and the general dimension the CBRN training per capita (P = 0.004), the number of personnel (P = 0.015), and laboratory equipment (P = 0.006) had a significant relationship with the preparedness of hospitals against CBRN incidents (P < 0.05). Conclusions: Overall, this study's results showed that hospitals' preparedness against CBRN incidents was unsatisfactory, and appropriate policies needed to be adopted to improve it.

26 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MAMarzieh Anjomshoa
Marzieh Anjomshoa
BABagher Amirheidari
Bagher Amirheidari
AKAlireza Kordjamshidi
Alireza Kordjamshidi
AFAlireza Farsinejad
Alireza Farsinejad
The clinical application of the metal complexes with promising anticancer activity is limited due to their extremely poor water solubility. To circumvent this, approaches based on drug delivery systems are routinely examined. Herein, an aqueous nanosuspension of a Cu(II) complex, [Cu(2MeObpy)2](PF6)2 where 2MeObpy is 4,4′-dimethoxy-2,2′-bipyridine, was prepared and stabilized with the non-ionic polysorbate 60 (Tween 60) (TW60) by using an antisolvent precipitation method. The optimized formulation (CuTW60-NS) was characterized by FT˗IR, UV˗Vis, dynamic light scattering (DLS), X˗ray diffraction (XRD) analysis, thermal analyses, and field emission scanning electron microscopy (FE˗SEM) in comparison with its Cu-S counterpart (water suspension). Anticancer activity of CuTW60-NS was compared with the Cu(II) complex dissolved in DMSO (Cu-DMSO) and Cisplatin towards the human glioblastoma cancer cells (U˗87) via a series of cellular and molecular techniques. CuTW60-NS showed a reduced particle size in the range of 400–700 nm along with high solubility and long-term stability. CuTW60-NS exhibited more efficient cytotoxicity against U˗87 after 48 h than Cu-DMSO with IC50 of 7.8 ± 0.7 µg/ml, a 2-fold reduction. High antimetastatic activity of CuTW60-NS against U-87 cells was observed through inhibition of cell migration and colony formation. CuTW60-NS promoted apoptotic cell death (70˗80%), further confirmed through molecular studies by regulation of apoptotic˗relevant BAX and BCL2 genes. This work presents the CuTW60-NS formulation as a promising anticancer agent, in view of the excellent improvement in its physicochemical and biological properties. In the end, this study opens a window to the development of the novel nanosuspension˗based delivery systems for insoluble metal complexes in cancer therapy.